Stock Traders Purchase High Volume of Put Options on UnitedHealth Group (UNH)

UnitedHealth Group Inc (NYSE:UNH) saw some unusual options trading on Monday. Stock investors acquired 333 put options on the stock. This is an increase of approximately 200% compared to the average daily volume of 111 put options.

In other news, Director Kenneth Irwin Shine sold 838 shares of the stock in a transaction dated Wednesday, April 19th. The stock was sold at an average price of $169.12, for a total value of $141,722.56. Following the completion of the sale, the director now owns 28,528 shares of the company’s stock, valued at $4,824,655.36. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP D Ellen Wilson sold 14,000 shares of the stock in a transaction dated Wednesday, April 19th. The shares were sold at an average price of $170.54, for a total value of $2,387,560.00. Following the completion of the sale, the executive vice president now directly owns 31,993 shares of the company’s stock, valued at approximately $5,456,086.22. The disclosure for this sale can be found here. In the last three months, insiders sold 40,148 shares of company stock valued at $6,806,849. Insiders own 1.65% of the company’s stock.

A number of institutional investors have recently modified their holdings of UNH. Private Capital Advisors Inc. raised its position in shares of UnitedHealth Group by 0.9% in the third quarter. Private Capital Advisors Inc. now owns 43,083 shares of the healthcare conglomerate’s stock valued at $6,032,000 after buying an additional 400 shares during the last quarter. Oakbrook Investments LLC raised its position in shares of UnitedHealth Group by 154.5% in the third quarter. Oakbrook Investments LLC now owns 54,075 shares of the healthcare conglomerate’s stock valued at $7,571,000 after buying an additional 32,825 shares during the last quarter. PGGM Investments raised its position in shares of UnitedHealth Group by 2.8% in the third quarter. PGGM Investments now owns 1,221,479 shares of the healthcare conglomerate’s stock valued at $171,007,000 after buying an additional 32,855 shares during the last quarter. Mizuho Securities USA Inc. raised its position in shares of UnitedHealth Group by 414.9% in the third quarter. Mizuho Securities USA Inc. now owns 30,814 shares of the healthcare conglomerate’s stock valued at $4,314,000 after buying an additional 24,829 shares during the last quarter. Finally, Heritage Investors Management Corp raised its position in shares of UnitedHealth Group by 42.7% in the third quarter. Heritage Investors Management Corp now owns 15,778 shares of the healthcare conglomerate’s stock valued at $2,209,000 after buying an additional 4,724 shares during the last quarter. 86.67% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group (NYSE:UNH) traded up 0.66% during mid-day trading on Friday, hitting $172.59. The company had a trading volume of 3,877,349 shares. UnitedHealth Group has a 52 week low of $130.01 and a 52 week high of $176.14. The firm has a market capitalization of $166.32 billion, a PE ratio of 22.09 and a beta of 0.68. The firm has a 50-day moving average price of $170.05 and a 200-day moving average price of $162.31.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The company had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. UnitedHealth Group’s revenue was up 9.4% compared to the same quarter last year. During the same period last year, the company posted $1.81 earnings per share. Equities analysts forecast that UnitedHealth Group will post $9.79 earnings per share for the current year.

Several brokerages recently commented on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price on the stock in a research report on Monday. CIBC upped their target price on UnitedHealth Group from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, April 24th. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $187.00 target price (up previously from $186.00) on shares of UnitedHealth Group in a research report on Friday, April 21st. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $205.00 price target (up previously from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Two research analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $182.65.

COPYRIGHT VIOLATION NOTICE: “Stock Traders Purchase High Volume of Put Options on UnitedHealth Group (UNH)” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://baseballnewssource.com/markets/investors-buy-large-volume-of-put-options-on-unitedhealth-group-unh-updated-updated-updated/629379.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with our FREE daily email newsletter.

 


Latest News

Zack Greinke Having Much Better Results This Season
Zack Greinke Having Much Better Results This Season
David Price and Red Sox to Meet Following Rehab Start
David Price and Red Sox to Meet Following Rehab Start
Lack of Offense Leading to Mediocrity for Boston Red Sox
Lack of Offense Leading to Mediocrity for Boston Red Sox
MLB and Facebook Announce Live Streaming for Games
MLB and Facebook Announce Live Streaming for Games
Can Anyway Stop the Houston Astros?
Can Anyway Stop the Houston Astros?
Kevin Pillar Turns from Defense to Offense
Kevin Pillar Turns from Defense to Offense


Leave a Reply

 
© 2006-2017 BBNS.